David Robert MICKLEM,Monica HELLESOY,Linn Hodneland NILSSON
申请号：
US15525623
公开号：
US20170314077A1
申请日:
2015.11.13
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The use of Slfn11 as a biomarker for detecting the occurrence of epithlial-to-mesenchymal transition (EMT) in a subject, and the use of Slfn11 modulators to treat cancer is disclosed herein. Also disclosed are various methods for detecting the occurrence of epithelial-to-mesenchymal transition (EMT) in a subject by measuring Slfn11 expression and/or activity.
